High sensitivity troponin outperforms contemporary assays in predicting major adverse cardiac events up to two years in patients with chest pain

Annals of Clinical Biochemistry

Volumn 48, Issue 3, 2011, Pages 249-255

  Aldous, Sally J ^a   Florkowski, Chris M ^b   Crozier, Ian G ^a   George, Peter ^b   Mackay, Richard ^b   Than, Martin ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REVASCULARIZATION; SENSITIVITY ANALYSIS; SURVIVAL RATE; THORAX PAIN;

BLOOD CHEMICAL ANALYSIS; CARDIOVASCULAR DISEASES; CHEST PAIN; COHORT STUDIES; DISEASE-FREE SURVIVAL; EMERGENCY MEDICAL SERVICES; FOLLOW-UP STUDIES; HUMANS; LIMIT OF DETECTION; REFERENCE VALUES; ROC CURVE; TROPONIN I; TROPONIN T;

EID: 79956106818     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2010.010220     Document Type: Article

References (25)

1. Morrow DA, Antman EM. Evaluation of high-sensitivity assays for cardiac troponin. Clin Chem 2009;55:5-8
2. Venge P, James S, Jansson L, Lindahl B. Clinical performance of two highly sensitive cardiac troponin I assays. Clin Chem 2009;55:109-16
3. White HD. Will new higher-precision troponins lead to clarity or confusion? Curr Opin Cardiol 2008;23:292-5
4. Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM. Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2008;54:723-8
5. Apple FS, Smith SW, Pearce LA, et al. Use of the bioMerieux VIDAS troponin I ultra assay for the diagnosis of myocardial infarction and detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chim Acta 2008;390:72-5
6. Agewall S, Olsson T, Lowbeer C. Usefulness of troponin levels below the diagnostic cut-off level for acute myocardial infarction in predicting prognosis in unselected patients admitted to the coronary care unit. Am J Cardiol 2007;99:1357-9
7. Tsai SH, Chu SJ, Hsu CW, Cheng SM, Yang SP. Use and interpretation of cardiac troponins in the ED. Am J Emerg Med 2008;26:331-41
8. Venge P, Lagerqvist B, Diderholm E, Lindahl B, Wallentin L. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). Am J Cardiol 2002;89:1035-41
9. Thygesen K, Alpert JS, White HD. Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-95
10. Apple FS, Parvin CA, Buechler KF, Christenson RH, Wu AH, Jaffe AS. Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem 2005;51:2198-9
11. Aldous SJ, Florkowski CM, Crozier IG, et al. Comparison of high sensity and contemporary troponin assays for the early detection of acute myocardial infarction in the emergency department. Ann Clin Biochem 2011;48:241-8
12. Cannon C, Battler A, Brindis R, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 2001;38:2114-30
13. Eggers KM, Jaffe AS, Lind L, Venge P, Lindahl P. Value of cardiac troponin I cut-off concentrations below the 99th percentile for clinical decision making. Clin chem. 2009;55:85-92
14. Schulz O, Paul-Walter C, Lehmann M, et al. Usefulness of detectable levels of troponin, below the 99th percentile of the normal range, as a clue to the presence of underlying coronary artery disease. Am J Cardiol 2007;100:764-9
15. Kavsak PA, Newman AM, Lustig V, et al. Long term health outcomes associated with detectable troponin I concentrations. Clin Chem 2007;53:220-7
16. Eggers KM, Lind L, Venge P, Lindahl B. Will the universal definition of myocardial infarction criteria result in an over diagnosis of myocardial infarction? Am J Cardio 2009;103:588-91
17. Apple F, Pearce L, Smith S, Kaczmarek J, Murakami M. Role of monitoring changes in sensitive cardiac troponin I assay for early diagnosis of myocardial infarction and prediction of risk of adverse events. Clin Chem 2009;55:930-39
18. Kavsak PA, Wang X, Ko DT, MacRae AR, Jaffe AS. Short and long term risk stratification using a next generation high sensitivity research cardiac troponin I assay in an ED chest pain population. Clin Chem 2009;55:1809-15
19. Babuin L, Vasile VC, Rio Perez JA, et al. Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Crit Care Med 2008;36:759-65
20. Daniels L, Laughlin G, Clopton P, Maisel A, Barrett-Connor E. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. Am Coll Cardiol 2008;52:450-9
21. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:869-77
22. Venge P, Johnston N, Lindahl B, James S. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol 2009;54:1165-72
23. Vasile VC, Saenger AK, Kroning JM, Jaffe AS. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:1086-90
24. Kavsak PA, Newman AM, Ko DT, et al. Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms? Clin Chem 2008;54:747-51
25. FS Apple. High-sensitivity cardiac troponin assays: what analytical and clinical issues need to be addressed before introduction into clinical practice? Clin Chem 2010;56:886-91